INVITRO RESPONSE OF BLASTOCYSTIS-HOMINIS TO ANTI-PROTOZOAL DRUGS

[1] BARILARI MJ, 1924, PRENSA MED ARGENT, V11, P854

[2] CALDERIN CC, 1937, REV MED TROP PARASIT, V3, P207

[3] MAZZA S, 1922, PRENSA MED ARGENT, V9, P460

[4] MCCLURE HM, 1980, LAB ANIM SCI, V30, P890

[5] BLASTOCYSTIS-HOMINIS - PATHOGENIC POTENTIAL IN HUMAN PATIENTS AND IN GNOTOBIOTES [J]. EXPERIMENTAL PARASITOLOGY, 1976, 36 (03) : 358 - 364

[6] SANGIOBGI G., 1930, Pathologica, V22, P173

[7] STECK EA, 1971, CHEMOTHERAPY PROTOZO, V1

[8] WENYON CM, 1917, J ROY ARMY MED CORPS, V28, P346

[9] THE TREATMENT OF INTESTINAL PROTOZOAN INFECTIONS [J]. MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (03) : 707 - 720

[10] WOOLFE G, 1963, EXP CHEMOTHER, V1, P355

[1] BARILARI MJ, 1924, PRENSA MED ARGENT, V11, P854

[2] CALDERIN CC, 1937, REV MED TROP PARASIT, V3, P207

[3] MAZZA S, 1922, PRENSA MED ARGENT, V9, P460

[4] MCCLURE HM, 1980, LAB ANIM SCI, V30, P890

[5] BLASTOCYSTIS-HOMINIS - PATHOGENIC POTENTIAL IN HUMAN PATIENTS AND IN GNOTOBIOTES [J]. EXPERIMENTAL PARASITOLOGY, 1976, 36 (03) : 358 - 364

[6] SANGIOBGI G., 1930, Pathologica, V22, P173

[7] STECK EA, 1971, CHEMOTHERAPY PROTOZO, V1

[8] WENYON CM, 1917, J ROY ARMY MED CORPS, V28, P346

[9] THE TREATMENT OF INTESTINAL PROTOZOAN INFECTIONS [J]. MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (03) : 707 - 720

[10] WOOLFE G, 1963, EXP CHEMOTHER, V1, P355